NO944669L - Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet - Google Patents

Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet

Info

Publication number
NO944669L
NO944669L NO944669A NO944669A NO944669L NO 944669 L NO944669 L NO 944669L NO 944669 A NO944669 A NO 944669A NO 944669 A NO944669 A NO 944669A NO 944669 L NO944669 L NO 944669L
Authority
NO
Norway
Prior art keywords
double
peptide compounds
chain peptide
group
hemoregulatory
Prior art date
Application number
NO944669A
Other languages
English (en)
Norwegian (no)
Other versions
NO944669D0 (no
Inventor
Kjell Undheim
Magne Solbakken
Peter Kremminger
Meinolf Lange
Erik Agner
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929211675A external-priority patent/GB9211675D0/en
Priority claimed from GB929211674A external-priority patent/GB9211674D0/en
Priority claimed from GB929211676A external-priority patent/GB9211676D0/en
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Publication of NO944669L publication Critical patent/NO944669L/no
Publication of NO944669D0 publication Critical patent/NO944669D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO944669A 1992-06-02 1994-12-02 Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet NO944669D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929211675A GB9211675D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211674A GB9211674D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211676A GB9211676D0 (en) 1992-06-02 1992-06-02 Peptide compounds
PCT/GB1993/001171 WO1993024523A1 (en) 1992-06-02 1993-06-02 Double chain peptide compounds having hemoregulatory activity

Publications (2)

Publication Number Publication Date
NO944669L true NO944669L (no) 1994-12-02
NO944669D0 NO944669D0 (no) 1994-12-02

Family

ID=27266223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944669A NO944669D0 (no) 1992-06-02 1994-12-02 Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet

Country Status (11)

Country Link
US (1) US5610141A (xx)
EP (1) EP0673388B1 (xx)
JP (1) JPH08501066A (xx)
CN (1) CN1086221A (xx)
AT (1) ATE172204T1 (xx)
AU (1) AU4340393A (xx)
DE (1) DE69321605D1 (xx)
EE (1) EE9400180A (xx)
LV (1) LV10288B (xx)
NO (1) NO944669D0 (xx)
WO (1) WO1993024523A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
ES2742299T3 (es) 2011-03-09 2020-02-13 Jitsubo Co Ltd Nuevos péptidos entrecruzados que contienen una estructura entrecruzada no peptídica, método para sintetizar péptidos entrecruzados y nuevo compuesto orgánico utilizado en el método
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
CN108059663A (zh) * 2018-02-10 2018-05-22 润辉生物技术（威海）有限公司 一种来考诺肽的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides

Also Published As

Publication number Publication date
US5610141A (en) 1997-03-11
ATE172204T1 (de) 1998-10-15
WO1993024523A1 (en) 1993-12-09
AU4340393A (en) 1993-12-30
EP0673388A1 (en) 1995-09-27
DE69321605D1 (de) 1998-11-19
EP0673388B1 (en) 1998-10-14
LV10288B (en) 1995-04-20
EE9400180A (et) 1996-02-15
NO944669D0 (no) 1994-12-02
JPH08501066A (ja) 1996-02-06
CN1086221A (zh) 1994-05-04
LV10288A (lv) 1994-10-20

Similar Documents

Publication Publication Date Title
TR199901971T2 (xx) Bir resept�re ba�lanan peptidler ve bile�ikler.
TR199701526T1 (xx) Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
YU34196A (sh) Peptidi i jedinjenja koja se vezuju za receptor
FR2662698B1 (xx)
NO991483D0 (no) Insulin C-peptider
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
DE69735502D1 (de) Mutanten des lag-3 proteins, ihre expression und verwendung
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
NO944669L (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet
DK0687180T3 (da) Fremgangsmåde til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-anti
EP0344006A3 (en) Peptides that block the binding of hiv-1 to th CD4 receptor protein
MY104909A (en) Peptide compounds.
NO944668L (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet
HU9300191D0 (en) Anti-coagulant peptides
DE68912689D1 (de) Legierung zum Aufpanzern von Ventilen.
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
DE69631624D1 (de) Antikörper gegen menschliches restrictin
NO984233L (no) Cytokin kalt lerk-8
ES2114170T3 (es) Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia.
NO962204L (no) Dobbeltkjedede hemoregulatoriske peptider
IT8485664A0 (it) Procedimento per il trattamento di liquami di conceria con ricupero di torbide proteiche utilizzabili in zootecnia.